Technology has transformed nearly every industry, and the furniture market is no exception, writes Deirdre Mc Gettrick, the ...

Rising imports of glass containers are just one sign of how the US lost its manufacturing culture. The value of ...

Taiwan Semiconductor Manufacturing (NYSE: TSM) stock lost ground in Tuesday's trading. The company's share price ended the day down 2.3% amid a 0.8% decline for the S&P 500 (SNPINDEX: ^GSPC ...

Not a club. But I like the concept." Cramer’s endorsement had limited effect, as the stock declined slightly by 0.55% since the call. Modine Manufacturing Company (NYSE:MOD) engineers thermal ...

According to White House estimates, building new pharmaceutical manufacturing capacity can take 5 to 10 years, which the administration considers “unacceptable from a national-security ...

We recently published a list of Domestic Manufacturing Boom ... our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds.

"You can see right now behind me is the ... PM Modi will inaugurate the Locomotive Manufacturing Shop at the Rolling Stock Workshop in Dahod, constructed by the Railway Ministry at a cost of ...

In this article, we are going to take a look at where Modine Manufacturing Company ... our research has shown that we can outperform the market by imitating the top stock picks of the best ...

In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Taiwan Semiconductor Manufacturing stock on April 21st. The trade occurred in the ...

We can do that very well in other locations ... Why It Matters: Trump’s selective manufacturing focus reflects broader economic pressures. A Harvard Business School study published May 17 ...

Taiwan Semiconductor Manufacturing is a key partner to chipmakers as they rely on the company's foundry services. While Taiwan Semi's growth prospects look bright, the stock is trading at a ...

Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharma plants in the United States, as part of new regulations to encourage domestic manufacturing.